Citation:Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al 2012

From Cancer Guidelines Wiki

Citation


Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012 Feb 1;30(4):419-25 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22203767.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al 2012What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Sperduto_PW,_Kased_N,_Roberge_D,_Xu_Z,_Shanley_R,_Luo_X,_et_al_2012&oldid=107198"